World Antidepressants Market Growth to 2030 and COVID-19 Implications
29 avr. 2021 06h33 HE
|
Research and Markets
Dublin, April 29, 2021 (GLOBE NEWSWIRE) -- The "Antidepressants Global Market Report 2021: COVID-19 Implications And Growth To 2030" report has been added to ResearchAndMarkets.com's offering. ...
Global Major Depressive Disorder (MDD) Drug Market Report 2021: Therapeutics Market Will Grow to $7.9B by 2029
19 avr. 2021 07h58 HE
|
Research and Markets
Dublin, April 19, 2021 (GLOBE NEWSWIRE) -- The "Major Depressive Disorder - Global Drug Forecast and Market Analysis to 2029" report has been added to ResearchAndMarkets.com's offering. The MDD...
Antidepressants Market to Touch USD 18.29 Billion by 2027; Growing Awareness about Mental Health Conditions to Fuel the Market: Fortune Business Insights™
08 mars 2021 04h27 HE
|
Fortune Business Insights
Pune, India, March 08, 2021 (GLOBE NEWSWIRE) -- The global antidepressants market size is projected to reach USD 18.29 billion by 2027, exhibiting a CAGR of 2.9% during the forecast period. The...
Global Psychedelic Therapeutics Market Report 2020: Regulation, Toxicity Concerns, Procurement-Related Challenges and Perceptions Regarding Medical Use
14 oct. 2020 04h59 HE
|
Research and Markets
Dublin, Oct. 14, 2020 (GLOBE NEWSWIRE) -- The "Global Psychedelic Therapeutics Market by Type of Psychedelic Substance, by Origin, by Type of Therapy, by Route of Administration and by Key...
Anxiety Disorder and Depression Treatment Market To Reach USD 18.90 Billion By 2026 | Reports And Data
15 mai 2019 13h27 HE
|
Reports And Data
The rise in the graying population and minimal side effects associated with the treatment are some of the factors boosting the market for Anxiety Disorder and Depression Treatment. Market Size – USD...
CCHR Florida Hosts Open House for Self-Harm Awareness Month
06 mars 2019 19h25 HE
|
Church of Scientology Flag Service Organization
CLEARWATER, Fla., March 06, 2019 (GLOBE NEWSWIRE) -- In order to raise awareness on the subject of self-harm as well as suicide, the Florida chapter of the Citizens Commission on Human Rights...
Neuronetics, Inc. Raises $30 Million in Series E Financing
16 mai 2011 08h30 HE
|
Neuronetics
MALVERN, PA--(Marketwire - May 16, 2011) - Neuronetics, Inc., maker of the NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy® System for the treatment of major depression*, announced today...
New Trial Data Confirm Clinical Effectiveness and Good Adherence Rates With NeuroStar TMS Therapy in Patients With Major Depressive Disorder Treated in a Real World Practice Setting
15 mai 2011 19h00 HE
|
Neuronetics
HONOLULU, HI--(Marketwire - May 15, 2011) - Results of a Neuronetics-sponsored, multisite observational study of patients with major depressive disorder (MDD) treated with Neuronetics' NeuroStar...
Neuronetics Receives TiE50 Award for Technology Entrepreneurship
09 mai 2011 08h30 HE
|
Neuronetics
MALVERN, PA--(Marketwire - May 9, 2011) - Neuronetics, Inc., maker of the NeuroStar Transcranial Magnetic Stimulation (TMS) Therapy® System, has been selected by TiE Silicon Valley as a 2011 recipient...
New Data Show No Negative Long-Term Effect in Cognitive Function in Patients With Major Depressive Disorder Treated With NeuroStar TMS Therapy(R)
14 avr. 2011 13h30 HE
|
Neuronetics
HONOLULU, HI--(Marketwire - Apr 14, 2011) - In an open-label study of patients with major depressive disorder (MDD) who had not benefitted from prior antidepressant medication and were treated with...